MARKET

ADMA

ADMA

Adma Biologics
NASDAQ
8.12
+0.19
+2.40%
Opening 13:59 05/29 EDT
OPEN
8.00
PREV CLOSE
7.93
HIGH
8.18
LOW
8.00
VOLUME
934.31K
TURNOVER
--
52 WEEK HIGH
22.37
52 WEEK LOW
7.21
MARKET CAP
1.88B
P/E (TTM)
11.97
1D
5D
1M
3M
1Y
5Y
1D
Insider Makes Bold Move With Fresh ADMA Biologics Buy
TipRanks · 15h ago
ADMA Biologics director Jerrold B. Grossman acquires 6,400 common shares worth $50,624
PUBT · 21h ago
New Strong Sell Stocks for May 26th
NASDAQ · 3d ago
Weekly Report: what happened at ADMA last week (0518-0522)?
Weekly Report · 4d ago
Rosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA
PR Newswire · 6d ago
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year
NASDAQ · 05/21 21:39
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
Barchart · 05/21 14:33
Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech
Benzinga · 05/18 14:12
More
About ADMA
ADMA Biologics, Inc. is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The Company manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.

Webull offers ADMA Biologics Inc stock information, including NASDAQ: ADMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADMA stock methods without spending real money on the virtual paper trading platform.